Attenuating Regulatory T Cell Induction by TLR Agonists through Inhibition of p38 MAPK Signaling in Dendritic Cells Enhances Their Efficacy as Vaccine Adjuvants and Cancer Immunotherapeutics
Andrew Jarnicki(Trinity College), Kingston H. G. Mills(Trinity College)
Cited by 136
Related Papers
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
|Clinical & Experimental Immunology|2010|960
Immune checkpoints and their inhibition in cancer and infectious diseases
|European Journal of Immunology|2017|537
Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?
|Cell Division|2010|237